ResApp Provides Update on Australian Clinical Study

View printer-friendly version Brisbane, Australia, 28 June 2018 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, today provided an update on its...

ResApp Receives Notice of Allowance for Core Patent in US

View printer-friendly version Brisbane, Australia, 6 June 2018 — ResApp Health Limited (ASX:RAP), a leading digital health company developing smartphone applications for the diagnosis and management of respiratory disease, is pleased to announce that the United...